Premenstrüel Sendrom ve Magnezyum

Premenstrual Syndrome and Magnesium

Yazarlar

  • Emine Tansu Okan Ankara Medipol Üniversitesi/Sağlık Bilimleri Enstitüsü/Beslenme ve Diyetetik Bölümü
  • İlknur Gökçe Yıldırım Ankara Medipol Üniversitesi/Sağlık Bilimleri Fakültesi/Beslenme ve Diyetetik Bölümü

DOI:

https://doi.org/10.51271/jashso.46

Anahtar Kelimeler:

premenstrüel sendrom- magnezyum- premenstrüel sendrom tedavisi

Özet

Premenstrüel Sendrom, üreme çağındaki kadınları etkileyen psikiyatrik, fizyolojik ve somatik semptomlarla karakterize bir bozukluktur. PMS’nin etiyolojisi belirsizliğini koruduğu için evrensel, kabul görmüş bir tedavi yöntemi bulunmamaktadır. Tedavide temel amaç semptomların hafifletilmesidir. Bilişsel Davranışcı Terapi (BDT), akupunktur, düzenli egzersiz, sağlıklı beslenme ve mineral takviyeleri tamamlayıcı tedavi yöntemleri arasında yer alır. Magnezyum, insan vücudunda birçok görevi olan, hastalıkların önlenmesi ve tedavisinde yer alan önemli bir mineraldir. Anksiyete, depresyon, sinirlilik, uykusuzluk, baş ağrısı, baş dönmesi, titreme ve psikotik davranış dahil olmak üzere çeşitli psikiyatrik bozukluklar Mg eksikliği ile ilişkilendirilir. Premenstrüel Sendrom’un semptomlarının hafifletilmesinde Magnezyum etkili bir ajan olabilir. Bu çalışmada premenstrüel sendrom ve magnezyum ilişkisi değerlendirilecektir.

   

Referanslar

1. Gudipally PR, Sharma GK. Premenstrual Syndrome. StatPearls. 2024.

2. Dilbaz B, Aksan A. Premenstrual syndrome, a common but underrated entity: review of the clinical literature. J Turk Ger Gynecol Assoc. 2021;22(2):139-148.

3. Yesildere Saglam H, Orsal O. Effect of exercise on premenstrual symptoms: A systematic review. Complet Ther Med. 2020; 48:102272.

4. Tiranini L, Nappi RE. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Fac Rev. 2022; 11:11.

5. Victor FF, Souza AI, Barreiros CDT, Barros JLND, Silva FACD, Ferreira ALCG. Quality of life among university students with premenstrual syndrome. Rev Bras Ginecol Obstet. 2019; 41:312-317.

6. Hashim MS, Obaideen AA, Jahrami HA, Radwan H, Hamad HJ, Owais AA, et al. Premenstrual syndrome is associated with dietary and lifestyle behaviors among university students: a cross-sectional study from Sharjah, UAE. Nutrients. 2019;11(8):1939.

7. Acikgoz A, Dayi A, Binbay T. Prevalence of premenstrual syndrome and its relationship to depressive symptoms in first-year university students. Saudi Med J. 2017; 38(11):1125.

8. Hernández-Hernández OT, Martínez-Mota L, Herrera-Pérez JJ, Jiménez-Rubio G. Role of estradiol in the expression of genes involved in serotonin neurotransmission: implications for female depression. Curr Neuropharmacol. 2019;17(5):459-471.

9. Paredes S, Cantillo S, Candido KD, Knezevic NN. An association of serotonin with pain disorders and its modulation by estrogens. Int J Mol Sci. 2019; 20(22):5729.

10. Reilly TJ, Wallman P, Clark I, Knox CL, Craig MC, Taylor D. Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials. J Psychopharmacol. 2023; 37(3):261-267.

11. Sacher J, Zsido RG, Barth C, Zientek F, Rullmann M, Luthardt J, et al. Increase in serotonin transporter binding in patients with premenstrual dysphoric disorder across the menstrual cycle: A case-control longitudinal neuroreceptor ligand positron emission tomography imaging study. Biol Psychiatry. 2023; 93(12):1081-1088.

12. Kancheva Landolt N, Ivanov K. Cognitive behavioral therapy-a primary mode for premenstrual syndrome management: systematic literature review. Psychol Health Med. 2021; 26(10):1282-1293.

13. Yang X, Zeng L, Huang J, Mo Z, Guan Z, Sun S, et al. Enhanced sludge dewaterability by a novel MnFe2O4-Biochar activated peroxymonosulfate process combined with Tannic acid. Chem Eng. J. 2022; 429:132280.

14. Pearce E, Jolly K, Jones LL, Matthewman G, Zanganeh M, Daley A. Exercise for premenstrual syndrome: a systematic review and meta-analysis of randomised controlled trials. BJGP Open. 2020; 4(3).

15. Siminiuc R, Ţurcanu D. Impact of nutritional diet therapy on premenstrual syndrome. Front Nutr. 2023; 10:1079417.

16. Zhang H, Zhu M, Song Y, Kong M. Baduanjin exercise improved premenstrual syndrome symptoms in Macau women. J Tradit Chin Med. 2014; 34(4):460-464.

17. Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2016; 94(3):236-240.

18. Verkaik S, Kamperman AM, van Westrhenen R, Schulte PF. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 217(2):150-166.

19. Zamani M, Neghab N, Torabian S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med Iran. 2012; 50(2):101-106.

20. Koleini S, Valiani M. Comparing the effect of auriculotherapy and vitamin B6 on the symptoms of premenstrual syndrome among the students who lived in the dorm of Isfahan university of medical sciences. Iran J Nurs Midwifery Res. 2017; 22(5):354-358.

21. Masruroh L, Muniroh L. The correlation between nutritional status and calcium adequace level on the ıncidence of premenstrual syndrome (PMS) ın female students at the faculty of public health universitas airlangga. Indones J Public Health. 2021; 16(3):426-436.

22. Arab A, Rafie N, Askari G, Taghiabadi M. Beneficial role of calcium in premenstrual syndrome: a systematic review of current literature. Int. J. Prev. Med. 2020; 11.

23. Bahrami A, Avan A, Sadeghnia HR, Esmaeili H, Tayefi M, Ghasemi F, et al. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol. 2018; 34(8):659-663.

24. Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015; 7(9):8199-8226.

25. Fathizadeh N, Ebrahimi E, Valiani M, Tavakoli N, Yar MH. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res. 2010; 15(Suppl 1):401-405.

26. Fiorentini D, Cappadone C, Farruggia G, Prata C. Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients. 2021; 13(4):1136.

27. Barbagallo M, Veronese N, Dominguez LJ. Magnesium in aging, health and diseases. Nutrients. 2021; 13(2):463.

28. Ebrahimi E, Motlagh SK, Nemati S, Tavakoli Z. Effects of magnesium and vitamin b6 on the severity of premenstrual syndrome symptoms. J Caring Sci. 2012; 1(4):183.

29. Quaranta S, Buscaglia MA, Meroni MG, Colombo E, Cella S. Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome. Clin Drug Investig. 2007; 27:51-58.

30. Sureja VP, Kheni DB, Dubey VP, Kansagra J, Soni ZK, Bhatt SP, et al. Efficacy and tolerability evaluation of a nutraceutical composition containing vitex agnus-castus extract (EVX40™), pyridoxine, and magnesium in premenstrual syndrome: a real-world, ınterventional, comparative study. Cureus. 2023; 15(8).

31. Saeedian Kia A, Amani R, Cheraghian B. The association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among university students: a case control study. Health Promot Perspect. 2015; 5(3):225-230.

İndir

Yayınlanmış

2026-01-29

Nasıl Atıf Yapılır

Okan, E. T., & Yıldırım, İlknur G. (2026). Premenstrüel Sendrom ve Magnezyum: Premenstrual Syndrome and Magnesium. Sağlık Bilimlerinde Ve Obezitede İleri Çalışmalar Dergisi, 2(1), 72–85. https://doi.org/10.51271/jashso.46

Sayı

Cilt 2 Sayı 1 (2026): Ocak

Bölüm

Beslenme ve Diyetetik

Lisans

All content published in Journal of Advanced Studies in Health Science and Obesity (JASHSO) is licensed under the Creative Commons CC BY 4.0 International License.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator.